Toxicities of 48 pharmaceuticals and their freshwater and marine environmental assessment in northwestern France

Environmental Science and Pollution Research

Volumn 23, Issue 6, 2016, Pages 4992-5001

  Minguez, Laetitia ^a,b   Pedelucq, Julie ^c   Farcy, Emilie ^a,b,d   Ballandonne, Céline ^b   Budzinski, Hélène ^c   Halm Lemeille, Marie Pierre ^b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

^c UNIVERSITÉ BORDEAUX 1   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

Aquatic environment; Ecotoxicity; Fate; MEC; PEC; Pharmaceuticals; Risk

Indexed keywords

CHEMICAL POLLUTANT; CRUSTACEAN; DIATOM; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; FRESHWATER ENVIRONMENT; GREEN ALGA; MARINE ENVIRONMENT; MEASUREMENT METHOD; RISK ASSESSMENT; TOXICITY;

BASSE NORMANDIE; FRANCE; ORNE RIVER;

ARTEMIA SALINA; BACILLARIOPHYTA; CHLOROPHYTA; CRUSTACEA; DAPHNIA MAGNA; SELENASTRUM CAPRICORNUTUM; SKELETONEMA MARINOI;

DRUG; FRESH WATER; WATER POLLUTANT;

ANALYSIS; ANIMAL; CHEMISTRY; DAPHNIA; DRUG EFFECTS; ECOSYSTEM; ENVIRONMENTAL MONITORING; FRANCE; GREEN ALGA; RISK ASSESSMENT; TOXICITY; WATER POLLUTANT;

ANIMALS; CHLOROPHYTA; DAPHNIA; ECOSYSTEM; ENVIRONMENTAL MONITORING; FRANCE; FRESH WATER; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL;

EID: 84908078151     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-014-3662-5     Document Type: Article

References (35)

1. Aminot Y (2013) Etude de l’impact des effluents urbains sur la qualité des eaux de la Garonne estuarienne: application aux composés pharmaceutiques et aux filtres UV Thèse de l’Université, n°4961, soutenue le 6/12/2013 (in French)
2. Backhaus T, Faust M (2012) Predictive environmental risk assessment of chemical mixtures: a conceptual framework. Environ Sci Technol 46:2564–2573
3. Backhaus T, Karlsson M (2014) Screening level mixture risk assessment of pharmaceuticals in STP effluents. Water Res 49(1):157–165
4. Backhaus T, Altenburger R, Arrhenius A, Blanck H, Faust M, Finizio A, Gramatica P, Grote M, Junghans M, Meyer W, Pavan M, Porsbring T, Scholze M, Todeschini R, Vighi M, Walter H, Grimme LH (2003) The BEAM-project: prediction and assessment of mixture toxicities in the aquatic environment
5. Besse JP, Garric J (2007) Médicaments à usage humain: risque d’exposition et effets sur les milieux récepteurs. Proposition d’une liste de médicaments à usage humain à surveiller dans les eaux de surfaces continentales, 238 p. Lyon: Agence de l’Eau RMC (in French)
6. Besse JP, Garric J (2008) Human pharmaceuticals in surface waters implementation of a prioritization methodology and application to the French situation. Toxicol Lett 176:104–123
7. Bound JP, Voulvoulis N (2006) Predicted and measured concentrations for selected pharmaceuticals in UK rivers: implications for risk assessment. Water Res 40:2885–2892
8. Brambilla G, Civitareale C, Migliore L (1994) Experimental toxicity and analysis of bacitracin, flumequine and sulphadimethoxine in terrestrial and aquatic organisms as a predictive model for ecosystem damage. Quim Anal 13:573–577
9. Claessens M, Vanhaecke L, Wille K, Janssen CR (2013) Emerging contaminants in Belgian marine waters: single toxicant and mixture risks of pharmaceuticals. Mar Pollut Bull 71:41–50
10. Commission of the European Communities (1996) Technical guidance document in support of commission directive 93/67/EEC on risk assessment for new notified substances and commission regulation (EC) No. 1488/94 on risk assessment for existing substances. Part II: environmental risk assessment. Office for Official Publications of the European Communities, Luxembourg
11. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107:907–938
12. Dévier MH, Le Ménach K, Viglino L, Di Gioia L, Lachassagne P, Budzinski H (2013) Ultra-trace analysis of hormones, pharmaceutical substances, alkylphenols and phtalates in two French natural mineral waters. Sci Total Environ 443:621–632
13. ECHA (2008) Guidance on information requirements and chemical safety assessment—part E: risk characterization. Guidance for the implementation of REACH
14. EMEA (2006) Note for guidance on environmental risk assessment of medicinal products for human use. Doc Ref EMEA/CHMP/SWP/4447/00. Committee for Proprietary Medicinal Products. European Agency for the Evaluation of Medicinal Products, London, UK. http://www.emea.eu.int/pdfs/human/swp/444700en.pdf
15. Enick OV, Moore MM (2007) Assessing the assessments: pharmaceuticals in the environment. Environ Impact Assess Rev 27:707–729
16. Fatta-Kassinos D, Meric S, Nikolaou A (2011) Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal Bioanal Chem 399:251–275
17. Fent K (2008) Effects of pharmaceuticals on aquatic organisms. In: Kümmerer K (ed) Pharmaceuticals in the environment—sources, fate, effects and risks. Springer-Verlag, pp 174–203
18. Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122–159
19. Ferrari B, Mons R, Vollat B, Fraysse B, Paxéus N, Lo Giudice R, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23(5):1344–1354
20. Hernando MD, Mezcua M, Fernández-Alba AR, Barceló D (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69:334–342
21. Isidori M, Lavorgna M, Nardelli A, Pascarella L, Parrella A (2005) Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci Total Environ 346(1–3):87–98
22. Jones OAH, Voulvoulis N, Lester JN (2002) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013–5022
23. Kümmerer K (2009) Antibiotics in the aquatic environment—a review—part I. Chemosphere 75:417–434
24. Marchand M, Tissier C (2005) L’analyse du risqué chimique en milieu marin: l’approche méthodologique européenne. Éd. Ifremer, 126p (in French)
25. NF EN ISO 10253 (2006) Qualité de l’eau – Essai d’inhibition de la croissance des algues marines avec Skeletonema costatum et Phaedactylum tricornutum (in French)
26. NF EN ISO 6341 (1996) Qualité de l’eau – Détermination de l’inhibition de la mobilité de Daphnia magna Straus (Cladocera, Crustacea) – Essai de toxicité aigüe (in French)
27. NF EN ISO 8692 (2012) Qualité de l’eau – Essai d’inhibition de la croissance des algues d’eau douce avec des algues vertes unicellulaires (in French)
28. OECD guidelines for the testing of chemicals N° 211 (1998) Daphnia magna reproduction test
29. Richardson SD, Ternes TA (2005) Water analysis: emerging contaminants and current issues. Anal Chem 77:3807–3838
30. Sánchez-Fortún S, Sanz F, Santa-María A, Ros JM, De Vicente ML, Encinas MT, Vinagre E, Brahona MV (1997) Acute sensitivity of three age classes of Artemia salina larvae to seven chlorinated solvents. Bull Environ Contam Toxicol 59:445–451
31. Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR (2004) Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharmacol 39:158–183
32. Togola A, Budzinski H (2008) Multi-residue analysis of pharmaceutical compounds in aqueous samples. J Chromatogr A 1177:150–158
33. Vindimian E (2012) MSExcel Macro Regtox 7.06 Freely available from Eric Vindimian. IRSTEA, France. http://www.normalesup.org/~vindimian (accessed March 2012)
34. Webb SF (2001) A data-based perspective on the environmental risk assessment of human pharmaceuticals I—collation of available ecotoxicity data. In: Kümmerer K (ed) Pharmaceuticals in the environment: source, fate, effects and risks. Springer, Berlin, pp 317–343
35. Wheeler JR, Grist EPM, Leung KMY, Morritt D, Crane M (2002) Species sensitivity distributions: data and model choice. Mar Pollut Bull 45:192–202